Table 2.
Baseline characteristics according to cancer therapeutic related cardiac dysfunction (CTRCD)
| All (n = 43) | non-CTRCD (n = 37) | CTRCD (n = 6) | |
|---|---|---|---|
| Age, years (mean, SD) | 58 ± 15 | 59 ± 14 | 48 ± 20 |
| Female Gender (n, %) | 26 (60.5%) | 21 (57%) | 5 (83%) |
| Hypertension (n, %) | 16 (37%) | 15 (41%) | 1 (17%) |
| Diabetes Mellitus (n, %) | 3 (7%) | 3 (8%) | 0 (0%) |
| Hyperlipidemia (n, %) | 8 (19%) | 8 (22%) | 0 (0%) |
| Past or Current Smoking (n, %) | 11 (26%) | 10 (27%) | 1 (17%) |
| Ischemic Heart Disease (n, %) | 1 (2%) | 1 (3%) | 0 (0%) |
| Atrial Fibrillation (n, %) | 2 (5%) | 2 (5%) | 0 (0%) |
| Ischemic Stroke (n, %) | 2 (5%) | 2 (5%) | 0 (0%) |
| Heart Rate, BPM (mean, SD) | 77.9(±13.6) | 78.3(±14.1) | 75(±9.8) |
| Systolic Blood Pressure, mmHg (mean, SD) | 124.6(±17.7) | 125.7(±17.3) | 116.8(±20.2) |
| Diastolic Blood Pressure, mmHg (mean, SD) | 70.5(±12.3) | 70.9(±12.5) | 67.6(±11.7) |
| O2 Saturation, % (mean, SD) | 98.4(±1.9) | 98.3(±2) | 98.8(±1.3) |
| Hemoglobin g/dL (mean, SD) | 11.3(±2.7) | 11.5(±2.7) | 10.3(±2.7) |
| White Blood Cells 10e3/μl (mean, SD) | 7.9(±3.4) | 7.7(±3.1) | 9.4(±5.1) |
| Red Blood Cell Distribution Width % (mean, SD) | 16.1(±2.4) | 15.7(±2.3) | 17.8(±2.6) |
| Platelets 10e3/μl (mean, SD) | 256.5(±116.7) | 233.9(±91.5) | 381(±166.9) |
| Creatinine mg/dL (mean, SD) | 0.8(±0.3) | 0.8(±0.2) | 0.6(±0.4) |
| Beta Blockers (n, %) | 9 (21%) | 6 (16%) | 3 (50%) |
| ACEI/ARBs (n, %) | 8 (18%) | 7 (19%) | 1 (17%) |
| Statins (n, %) | 10 (23%) | 10 (27%) | 0 (0%) |
SD standard deviation, ACEI angiotensin-converting-enzyme inhibitors, ARB Angiotensin II receptor blockers